More than 180 international focused ultrasound experts gathered in London at the Royal Geographic Society for the 3rd European Symposium on Focused Ultrasound Therapy, held October 15-16.
The robust agenda concentrated on current and developing clinical applications and featured expert panels describing the details, successes, and challenges of performing individual procedures.
“Other meetings have covered the scientific basis of the technology,” said symposium organizer Wladyslaw Gedroyc of St. Mary’s Hospital/Imperial College NHS Trust in London. “The presentations at this year’s conference truly highlighted the current state-of-the art from a clinical perspective. The indications, the specific procedures, and current challenges created the core of the material presented to the attendees.”
“The topics and panel discussions at the meeting demonstrated the rapid expansion of conditions that can be treated with focused ultrasound, including promising data on pancreatic cancer,” said Foundation Chairman Neal F. Kassell, MD.
The clinically based program covered detailed information about treating patients with a broad range of conditions using various manufacturers’ systems and included:
- Uterine fibroids with an update on infertility
- Prostate cancer
- Bone tumors and malformations
- Liver cancer (hepatocellular carcinoma)
- Brain procedures using 1.5T and opening the blood-brain barrier
- Drug activation